Patient safety is paramount in regulating new stem cell treatments.
Patient safety is paramount in regulating new stem cell treatments.
A senior cardiovascular disease and diabetes researcher at the University of Kentucky has been found guilty of falsifying data over the past 10 years.
| November 1, 2012
Meet some of the people featured in the November 2012 issue of The Scientist.
The latest news from a long-term study of calorie restriction in rhesus macaques shows better health, but no boost in lifespan, in monkeys who eat less.
Results from a Phase II trial for cardiovascular disease with an epigenetic target therapy show promise.
After a historic UN meeting, global efforts must be coordinated against noncommunicable diseases to thwart the world’s leading causes of death and disability.
A journal halts publication of a study on the benefits of meditation for heart disease to review additional data.
Stress and inflammation Cardiovascular disease, including coronary artery disease and stroke, is the single greatest cause of death worldwide and is a major burden on health services and society. Most resources are currently directed towards surg
Fast blood flow protects against atherosclerosis: implications for treatment
Page 1 of 1